- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chemotherapy in Netherlands
Total 20 results
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Leiden University Medical Center; Reinier de GraafRecruitingChemotherapy-induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral Neuropathy | Qutenza | DuloxetineNetherlands
-
University Medical Center GroningenRecruitingToxicity Due to Chemotherapy | Cancer, Treatment-Related | Cardiovascular MorbidityNetherlands
-
Radboud University Medical CenterErasmus Medical Center; Medisch Centrum LeeuwardenRecruitingCancer | Physical Activity | Toxicity Due to Chemotherapy | Systemic TreatmentNetherlands
-
Daniëlle van de GraafComprehensive Cancer Centre The Netherlands; Dutch Cancer SocietyRecruitingChemotherapy-induced Peripheral Neuropathy | Cancer SurvivorsNetherlands
-
Prolong PharmaceuticalsTerminatedChemotherapy-induced NeutropeniaFrance, Netherlands
-
Borstkanker Onderzoek GroepUMC Utrecht; Erasmus Medical Center; Servier; BOOG Study CenterActive, not recruitingBreast Neoplasm | Chemotherapy EffectNetherlands
-
Radboud University Medical CenterUnknownNeoplasms | Ovarian Neoplasms | Effects of Chemotherapy | Immune ToleranceNetherlands
-
Amsterdam UMC, location VUmcRecruitingRecurrence | Colorectal Cancer | Surgery | Chemotherapy Effect | Liver Metastases | Liver Metastasis Colon CancerNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedBleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus CancerNetherlands
-
Radboud University Medical CenterUnknownBreast Cancer | Cardiotoxicity | Chemotherapy Induced Systolic DysfunctionNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...M.D. Anderson Cancer Center; University of Colorado, Denver; Radboud University... and other collaboratorsRecruitingPancreatic Cancer | Chemotherapy Effect | Locally Advanced Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma Non-resectableNetherlands
-
Leiden University Medical CenterThe Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaboratorsSuspendedHER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response RateNetherlands
-
Leiden University Medical CenterAmgen; Borstkanker Onderzoek Groep; Pink Ribbon Inc.CompletedBreast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete ResponseNetherlands
-
Merck Sharp & Dohme LLCCompletedChemotherapy-induced Nausea and VomitingUnited States, Greece, Hungary, Lithuania, Netherlands, Peru, Poland, Russian Federation, United Kingdom
-
GlaxoSmithKlineCompletedNausea and Vomiting | Chemotherapy-InducedTaiwan, Belgium, Singapore, Netherlands, Mexico, Slovakia, Italy, Philippines, Austria, Chile, Romania, Poland, Czech Republic, Hungary, Pakistan, Croatia, Peru, Argentina, Hong Kong
-
Vall d'Hebron Institute of OncologyEuropean Organisation for Research and Treatment of Cancer - EORTCTerminatedChemotherapy | ColoRectal Cancer | MSI | Resistance, APCBelgium, Netherlands, Spain, Italy
-
Academisch Ziekenhuis MaastrichtZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedBreast Cancer | Febrile Neutropenia | ChemotherapyNetherlands
-
Leiden University Medical CenterDutch Colorectal Cancer Group; Stichting DarmkankerNot yet recruitingColorectal Cancer | Metastatic Cancer | Older Patients | Candidates for Palliative ChemotherapyNetherlands
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain